ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS

Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can… Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI

Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry… Read More

CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will… Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS

Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to… Read More

CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES

Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma… Read More

ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug… Read More

CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING

Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While… Read More

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t… Read More

BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES

Committee Report Shows How Brand Name Drug Company Further Juiced Profits on… Read More

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES

Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of… Read More

DOSE OF REALITY: PATENT HEARINGS OFFER OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE PRACTICES

Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives… Read More

SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN

Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade… Read More

© 2026 CSRXP- All Rights Reserved